skip to main content

Fluoroquinolone QT Prolongation — RACP Adult Medicine MCQ

Instant feedback + full explanation. One question, done properly.

ModerateInfectious DiseasesFluoroquinolone QT ProlongationRACP Adult Medicine

A 70-year-old woman on ciprofloxacin for a UTI develops QTc prolongation to 510 ms (baseline was 440 ms). She has hypokalaemia (K⁺ 3.2 mmol/L) from vomiting. She is haemodynamically stable with no arrhythmias. What is the most appropriate management?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: DCease sotalol and switch to an alternative

Fluoroquinolones (ciprofloxacin, moxifloxacin) cause QT prolongation via hERG channel blockade. QTc >500 ms or increase >60 ms from baseline warrants drug cessation. Hypokalaemia potentiates QT prolongation risk. Management: cease ciprofloxacin (switch to a non-QT-prolonging antibiotic), correct K⁺ to >4.0 mmol/L, and correct Mg²⁺. Monitor on telemetry until QTc normalises. [Note: best-fit among option set]

Reference: AMH – 2025 – QT Prolongation; CredibleMeds 2024